Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159 Results filed 13 Aug 2026

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pardeep Nijhawan
Chief Executive Officer
—
—
—
1,875,402
$12.38M
+88.5%
Michael J Brooks
President
—
—
—
291,479
$1.92M
+1,550%
Peter J. Weiler
Chief Financial Officer
—
—
—
129,609
$855.28K
—
Patrick Marshall
Director
—
—
—
71,666
$472.92K
—
Carlo Sistilli
Director
—
—
—
49,417
$326.10K
—
Sean Arthur MacDonald
Director
—
—
—
41,054
$270.91K
+1,900%
Joan Chypyha
Director
—
—
—
30,029
$198.16K
+103,448%
Charles Olson V
Director
—
—
—
30,000
$197.97K
—
Da David Liu
Director
—
—
—
24,501
$161.68K
—

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.